Skip to main content
Top
Published in: BMC Pediatrics 1/2019

Open Access 01-12-2019 | Angioedema | Research article

Significant predictive factors of the severity and outcomes of the first attack of acute angioedema in children

Authors: Yuan-Jhen Syue, Chao-Jui Li, Wen-Liang Chen, Tsung-Han Lee, Cheng-Chieh Huang, Mei-Chueh Yang, Chih-Ming Lin, Meng-Huan Wu, Chu-Chung Chou, Chin-Fu Chang, Yan-Ren Lin

Published in: BMC Pediatrics | Issue 1/2019

Login to get access

Abstract

Background

The initial episode of angioedema in children can be potential life-threatening due to the lack of prompt identification and treatment. We aimed to analyze the factors predicting the severity and outcomes of the first attack of acute angioedema in children.

Methods

This was a retrospective study with 406 children (< 18 years) who presented in the emergency department (ED) with an initial episode of acute angioedema and who had subsequent follow-up visits in the out-patient department from January 2008 to December 2014. The severity of the acute angioedema was categorized as severe (requiring hospital admission), moderate (requiring a stay in the short-term pediatric observation unit [POU]), or mild (discharged directly from the ED). The associations among the disease severity, patient demographics and clinical presentation were analyzed.

Result

In total, 109 (26.8%) children had severe angioedema, and the majority of those children were male (65.1%). Most of the children were of preschool age (56.4%), and only 6.4% were adolescents. The co-occurrence of pyrexia or urticaria, etiologies of the angioedema related to medications or infections, the presence of respiratory symptoms, and a history of allergies (asthma, allergic rhinitis) were predictors of severe angioedema (all p < 0.05). Finally, the duration of angioedema was significantly shorter in children who had received short-term POU treatment (2.1 ± 1.1 days) than in those who discharged from ED directly (2.3 ± 1.4 days) and admitted to the hospital (3.5 ± 2.0 days) (p < 0.001).

Conclusion

The co-occurrence of pyrexia or urticaria, etiologies related to medications or infections, the presence of respiratory symptoms, and a history of allergies were predictors of severe angioedema. More importantly, short-term POU observation and prompt treatment might be benefit for patients who did not require hospital admission.
Literature
1.
go back to reference Bas M. The angiotensin-converting-enzyme-induced angioedema. Immunol Allergy Clin N Am. 2017;37(1):183–200.CrossRef Bas M. The angiotensin-converting-enzyme-induced angioedema. Immunol Allergy Clin N Am. 2017;37(1):183–200.CrossRef
2.
go back to reference Cicardi M, Suffritti C, Perego F, Caccia S. Novelties in the Diagnosis and Treatment of Angioedema. J Investig Allergol Clin Immunol. 2016;26(4):212–21 quiz two pages after page 221.CrossRef Cicardi M, Suffritti C, Perego F, Caccia S. Novelties in the Diagnosis and Treatment of Angioedema. J Investig Allergol Clin Immunol. 2016;26(4):212–21 quiz two pages after page 221.CrossRef
3.
go back to reference Lewis LM. Angioedema: etiology, pathophysiology, current and emerging therapies. J Emerg Med. 2013;45(5):789–96.CrossRef Lewis LM. Angioedema: etiology, pathophysiology, current and emerging therapies. J Emerg Med. 2013;45(5):789–96.CrossRef
4.
go back to reference Bernstein JA, Cremonesi P, Hoffmann TK, Hollingsworth J. Angioedema in the emergency department: a practical guide to differential diagnosis and management. Int J Emerg Med. 2017;10(1):15–017-0141-z Epub 2017 Apr 13.CrossRef Bernstein JA, Cremonesi P, Hoffmann TK, Hollingsworth J. Angioedema in the emergency department: a practical guide to differential diagnosis and management. Int J Emerg Med. 2017;10(1):15–017-0141-z Epub 2017 Apr 13.CrossRef
5.
go back to reference Depetri F, Tedeschi A, Cugno M. Angioedema and emergency medicine: from pathophysiology to diagnosis and treatment. Eur J Intern Med. 2019;59:8–13.CrossRef Depetri F, Tedeschi A, Cugno M. Angioedema and emergency medicine: from pathophysiology to diagnosis and treatment. Eur J Intern Med. 2019;59:8–13.CrossRef
6.
go back to reference Long BJ, Koyfman A, Gottlieb M. Evaluation and Management of Angioedema in the emergency department. West J Emerg Med. 2019;20(4):587–600.CrossRef Long BJ, Koyfman A, Gottlieb M. Evaluation and Management of Angioedema in the emergency department. West J Emerg Med. 2019;20(4):587–600.CrossRef
7.
go back to reference Takazawa T, Oshima K, Saito S. Drug-induced anaphylaxis in the emergency room. Acute Med Surg. 2017;4(3):235–45.CrossRef Takazawa T, Oshima K, Saito S. Drug-induced anaphylaxis in the emergency room. Acute Med Surg. 2017;4(3):235–45.CrossRef
8.
go back to reference Montanez MI, Mayorga C, Bogas G, Barrionuevo E, Fernandez-Santamaria R, Martin-Serrano A, Laguna JJ, Torres MJ, Fernandez TD, Dona I. Epidemiology, mechanisms, and diagnosis of drug-induced anaphylaxis. Front Immunol. 2017;8:614.CrossRef Montanez MI, Mayorga C, Bogas G, Barrionuevo E, Fernandez-Santamaria R, Martin-Serrano A, Laguna JJ, Torres MJ, Fernandez TD, Dona I. Epidemiology, mechanisms, and diagnosis of drug-induced anaphylaxis. Front Immunol. 2017;8:614.CrossRef
9.
go back to reference Javaud N, Achamlal J, Reuter PG, Lapostolle F, Lekouara A, Youssef M, Hamza L, Karami A, Adnet F, Fain O. Angioedema related to angiotensin-converting enzyme inhibitors: attack severity, treatment, and hospital admission in a prospective multicenter study. Medicine (Baltimore). 2015;94(45):e1939.CrossRef Javaud N, Achamlal J, Reuter PG, Lapostolle F, Lekouara A, Youssef M, Hamza L, Karami A, Adnet F, Fain O. Angioedema related to angiotensin-converting enzyme inhibitors: attack severity, treatment, and hospital admission in a prospective multicenter study. Medicine (Baltimore). 2015;94(45):e1939.CrossRef
10.
go back to reference Mahmoudpour SH, Leusink M, van der Putten L, Terreehorst I, Asselbergs FW, de Boer A. Maitland-van der zee AH: Pharmacogenetics of ACE inhibitor-induced angioedema and cough: a systematic review and meta-analysis. Pharmacogenomics. 2013;14(3):249–60.CrossRef Mahmoudpour SH, Leusink M, van der Putten L, Terreehorst I, Asselbergs FW, de Boer A. Maitland-van der zee AH: Pharmacogenetics of ACE inhibitor-induced angioedema and cough: a systematic review and meta-analysis. Pharmacogenomics. 2013;14(3):249–60.CrossRef
11.
go back to reference Banerji A, Blumenthal KG, Lai KH, Zhou L. Epidemiology of ACE inhibitor angioedema utilizing a large electronic health record. J Allergy Clin Immunol Pract. 2017;5(3):744–9.CrossRef Banerji A, Blumenthal KG, Lai KH, Zhou L. Epidemiology of ACE inhibitor angioedema utilizing a large electronic health record. J Allergy Clin Immunol Pract. 2017;5(3):744–9.CrossRef
12.
go back to reference Banerji A, Clark S, Blanda M, LoVecchio F, Snyder B, Camargo CA Jr. Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department. Ann Allergy Asthma Immunol. 2008;100(4):327–32.CrossRef Banerji A, Clark S, Blanda M, LoVecchio F, Snyder B, Camargo CA Jr. Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department. Ann Allergy Asthma Immunol. 2008;100(4):327–32.CrossRef
13.
go back to reference James C, Bernstein JA. Current and future therapies for the treatment of histamine-induced angioedema. Expert Opin Pharmacother. 2017;18(3):253–62.CrossRef James C, Bernstein JA. Current and future therapies for the treatment of histamine-induced angioedema. Expert Opin Pharmacother. 2017;18(3):253–62.CrossRef
14.
go back to reference Ohsawa I, Honda D, Hisada A, Inoshita H, Onda-Tsueshita K, Mano S, Sato N, Nakamura Y, Shimizu T, Gotoh H, Goto Y, Suzuki Y, Tomino Y. Clinical features of hereditary and mast cell-mediated angioedema focusing on the differential diagnosis in Japanese patients. Intern Med. 2018;57(3):319–24.CrossRef Ohsawa I, Honda D, Hisada A, Inoshita H, Onda-Tsueshita K, Mano S, Sato N, Nakamura Y, Shimizu T, Gotoh H, Goto Y, Suzuki Y, Tomino Y. Clinical features of hereditary and mast cell-mediated angioedema focusing on the differential diagnosis in Japanese patients. Intern Med. 2018;57(3):319–24.CrossRef
15.
go back to reference Nzeako UC. Diagnosis and management of angioedema with abdominal involvement: a gastroenterology perspective. World J Gastroenterol. 2010;16(39):4913–21.CrossRef Nzeako UC. Diagnosis and management of angioedema with abdominal involvement: a gastroenterology perspective. World J Gastroenterol. 2010;16(39):4913–21.CrossRef
17.
go back to reference Banerji A. Current treatment of hereditary angioedema: an update on clinical studies. Allergy Asthma Proc. 2010;31(5):398–406.CrossRef Banerji A. Current treatment of hereditary angioedema: an update on clinical studies. Allergy Asthma Proc. 2010;31(5):398–406.CrossRef
18.
go back to reference Floccard B, Javaud N, Deroux A, Boccon-Gibod I, Fain O, Amarger S, Blanchard-Delaunay C, Jeandel PY, Marmion N, Ollivier Y, Pralong P, Gayet S, Du-Thanh A, Pelletier F, Sailler L, Robinson P, Launay D, Bouillet L. French reference Centre for Angioedema (CREAK): diagnosis and treatment of upper airway oedema caused by acute angio-oedema in the emergency department: a French consensus statement. Eur J Emerg Med. 2017;24(5):318–25.CrossRef Floccard B, Javaud N, Deroux A, Boccon-Gibod I, Fain O, Amarger S, Blanchard-Delaunay C, Jeandel PY, Marmion N, Ollivier Y, Pralong P, Gayet S, Du-Thanh A, Pelletier F, Sailler L, Robinson P, Launay D, Bouillet L. French reference Centre for Angioedema (CREAK): diagnosis and treatment of upper airway oedema caused by acute angio-oedema in the emergency department: a French consensus statement. Eur J Emerg Med. 2017;24(5):318–25.CrossRef
19.
go back to reference Dhami S, Sheikh A. Anaphylaxis: epidemiology, aetiology and relevance for the clinic. Expert Rev Clin Immunol. 2017;13(9):889–95.CrossRef Dhami S, Sheikh A. Anaphylaxis: epidemiology, aetiology and relevance for the clinic. Expert Rev Clin Immunol. 2017;13(9):889–95.CrossRef
20.
go back to reference Chan JCK, Peters RL, Koplin JJ, Dharmage SC, Gurrin LC, Wake M, Tang MLK, Prescott S, Allen KJ. Health Nuts Study: Food Challenge and Community-Reported Reaction Profiles in Food-Allergic Children Aged 1 and 4 Years: A Population-Based Study. J Allergy Clin Immunol Pract. 2017;5(2):398–409.e3.CrossRef Chan JCK, Peters RL, Koplin JJ, Dharmage SC, Gurrin LC, Wake M, Tang MLK, Prescott S, Allen KJ. Health Nuts Study: Food Challenge and Community-Reported Reaction Profiles in Food-Allergic Children Aged 1 and 4 Years: A Population-Based Study. J Allergy Clin Immunol Pract. 2017;5(2):398–409.e3.CrossRef
21.
go back to reference Kudryavtseva AV, Neskorodova KA, Staubach P. Urticaria in children and adolescents: an updated review of the pathogenesis and management. Pediatr Allergy Immunol. 2019;30(1):17–24.CrossRef Kudryavtseva AV, Neskorodova KA, Staubach P. Urticaria in children and adolescents: an updated review of the pathogenesis and management. Pediatr Allergy Immunol. 2019;30(1):17–24.CrossRef
22.
go back to reference Greaves MW, Hussein SH. Drug-induced urticaria and angioedema: pathomechanisms and frequencies in a developing country and in developed countries. Int Arch Allergy Immunol. 2002;128(1):1–7.CrossRef Greaves MW, Hussein SH. Drug-induced urticaria and angioedema: pathomechanisms and frequencies in a developing country and in developed countries. Int Arch Allergy Immunol. 2002;128(1):1–7.CrossRef
23.
go back to reference Gomes ER, Brockow K, Kuyucu S, Saretta F, Mori F, Blanca-Lopez N, Ott H, Atanaskovic-Markovic M, Kidon M, Caubet JC, Terreehorst I. ENDA/EAACI drug allergy interest group: drug hypersensitivity in children: report from the pediatric task force of the EAACI drug allergy interest group. Allergy. 2016;71(2):149–61.CrossRef Gomes ER, Brockow K, Kuyucu S, Saretta F, Mori F, Blanca-Lopez N, Ott H, Atanaskovic-Markovic M, Kidon M, Caubet JC, Terreehorst I. ENDA/EAACI drug allergy interest group: drug hypersensitivity in children: report from the pediatric task force of the EAACI drug allergy interest group. Allergy. 2016;71(2):149–61.CrossRef
24.
25.
go back to reference Kelly C, Gangur V. Sex disparity in food allergy: evidence from the PubMed database. J Allergy (Cairo). 2009;2009:159845. Kelly C, Gangur V. Sex disparity in food allergy: evidence from the PubMed database. J Allergy (Cairo). 2009;2009:159845.
26.
go back to reference Frank MM, Zuraw B, Banerji A, Bernstein JA, Craig T, Busse P, Christiansen S, Davis-Lorton M, Li HH, Lumry WR, Riedl M. US Hereditary Angioedema Association Medical Advisory Board: Management of Children With Hereditary Angioedema Due to C1 Inhibitor Deficiency. Pediatrics. 2016;138(5). https://doi.org/10.1542/peds.2016-0575.CrossRef Frank MM, Zuraw B, Banerji A, Bernstein JA, Craig T, Busse P, Christiansen S, Davis-Lorton M, Li HH, Lumry WR, Riedl M. US Hereditary Angioedema Association Medical Advisory Board: Management of Children With Hereditary Angioedema Due to C1 Inhibitor Deficiency. Pediatrics. 2016;138(5). https://​doi.​org/​10.​1542/​peds.​2016-0575.CrossRef
27.
go back to reference Wahn V, Aberer W, Eberl W, Fasshauer M, Kuhne T, Kurnik K, Magerl M, Meyer-Olson D, Martinez-Saguer I, Spath P, Staubach-Renz P, Kreuz W. Hereditary angioedema (HAE) in children and adolescents--a consensus on therapeutic strategies. Eur J Pediatr. 2012;171(9):1339–48.CrossRef Wahn V, Aberer W, Eberl W, Fasshauer M, Kuhne T, Kurnik K, Magerl M, Meyer-Olson D, Martinez-Saguer I, Spath P, Staubach-Renz P, Kreuz W. Hereditary angioedema (HAE) in children and adolescents--a consensus on therapeutic strategies. Eur J Pediatr. 2012;171(9):1339–48.CrossRef
28.
go back to reference Fisher HR, Du Toit G, Bahnson HT, Lack G. The challenges of preventing food allergy: lessons learned from LEAP and EAT. Ann Allergy Asthma Immunol. 2018;121(3):313–9.CrossRef Fisher HR, Du Toit G, Bahnson HT, Lack G. The challenges of preventing food allergy: lessons learned from LEAP and EAT. Ann Allergy Asthma Immunol. 2018;121(3):313–9.CrossRef
29.
go back to reference Lee S. IgE-mediated food allergies in children: prevalence, triggers, and management. Korean J Pediatr. 2017;60(4):99–105.CrossRef Lee S. IgE-mediated food allergies in children: prevalence, triggers, and management. Korean J Pediatr. 2017;60(4):99–105.CrossRef
31.
go back to reference Gandhi J, Jones R, Teubner D, Gabb G. Multicentre audit of ACE-inhibitor associated angioedema (MAAAA). Aust Fam Physician. 2015;44(8):579–83.PubMed Gandhi J, Jones R, Teubner D, Gabb G. Multicentre audit of ACE-inhibitor associated angioedema (MAAAA). Aust Fam Physician. 2015;44(8):579–83.PubMed
32.
go back to reference LoVerde D, Files DC, Krishnaswamy G. Angioedema. Crit Care Med. 2017;45(4):725–35.CrossRef LoVerde D, Files DC, Krishnaswamy G. Angioedema. Crit Care Med. 2017;45(4):725–35.CrossRef
33.
go back to reference Pattanaik D, Lieberman JA. Pediatric angioedema. Curr Allergy Asthma Rep. 2017;17(9):60-017–0729-7.CrossRef Pattanaik D, Lieberman JA. Pediatric angioedema. Curr Allergy Asthma Rep. 2017;17(9):60-017–0729-7.CrossRef
34.
go back to reference Axelrod S, Davis-Lorton M. Urticaria and angioedema. Mt Sinai J Med. 2011;78(5):784–802.CrossRef Axelrod S, Davis-Lorton M. Urticaria and angioedema. Mt Sinai J Med. 2011;78(5):784–802.CrossRef
35.
go back to reference Kanani A, Schellenberg R, Warrington R. Urticaria and angioedema. Allergy Asthma Clin Immunol. 2011;7(Suppl 1):S9 1492-7-S1-S9.CrossRef Kanani A, Schellenberg R, Warrington R. Urticaria and angioedema. Allergy Asthma Clin Immunol. 2011;7(Suppl 1):S9 1492-7-S1-S9.CrossRef
36.
go back to reference Altman K, Chang C. Pathogenic intracellular and autoimmune mechanisms in urticaria and angioedema. Clin Rev Allergy Immunol. 2013;45(1):47–62.CrossRef Altman K, Chang C. Pathogenic intracellular and autoimmune mechanisms in urticaria and angioedema. Clin Rev Allergy Immunol. 2013;45(1):47–62.CrossRef
37.
go back to reference Lin YR, Liu TH, Wu TK, Chang YJ, Chou CC, Wu HP. Predictive factors of the duration of a first-attack acute urticaria in children. Am J Emerg Med. 2011;29(8):883–9.CrossRef Lin YR, Liu TH, Wu TK, Chang YJ, Chou CC, Wu HP. Predictive factors of the duration of a first-attack acute urticaria in children. Am J Emerg Med. 2011;29(8):883–9.CrossRef
38.
go back to reference Wu MA, Perego F, Zanichelli A, Cicardi M. Angioedema phenotypes: disease expression and classification. Clin Rev Allergy Immunol. 2016;51(2):162–9.CrossRef Wu MA, Perego F, Zanichelli A, Cicardi M. Angioedema phenotypes: disease expression and classification. Clin Rev Allergy Immunol. 2016;51(2):162–9.CrossRef
Metadata
Title
Significant predictive factors of the severity and outcomes of the first attack of acute angioedema in children
Authors
Yuan-Jhen Syue
Chao-Jui Li
Wen-Liang Chen
Tsung-Han Lee
Cheng-Chieh Huang
Mei-Chueh Yang
Chih-Ming Lin
Meng-Huan Wu
Chu-Chung Chou
Chin-Fu Chang
Yan-Ren Lin
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2019
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-019-1809-8

Other articles of this Issue 1/2019

BMC Pediatrics 1/2019 Go to the issue